08:48 AM EDT, 03/28/2025 (MT Newswires) -- GSK (GSK) wants the UK government to make its public health data records more accessible to pharmaceutical firms to boost drug development, Bloomberg reported Friday.

At a meeting last August with Science Minister Patrick Vallance, GSK Chief Scientific Officer Tony Wood pitched the idea for the government to invest in more effectively linking clinical, genomic, and primary care datasets and to make them available to researchers and firms, the report said, citing a Freedom of Information request by Bloomberg.

The UK Office for Life Sciences is coordinating with several funding organizations on the plan's feasibility, the report said, citing internal notes of a later meeting with the firm obtained through a second FOI filing.

"We fully support GSK's potential partnership and see this as an opportunity to cement the UK as a destination for world-leading [research and development]," the report quoted a government spokesperson as saying in an email.

GSK and the UK Office for Life Sciences didn't immediately respond to requests for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)